Daxor Corporation (NASDAQ: DXR) Stock Information | RedChip

Daxor Corporation (NASDAQ: DXR) Listen to this Section


$8.89
-0.1100 ( -1.22% ) 0.0K

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Market Data


Open


$8.89

Previous close


$9.00

Volume


0.0K

Market cap


$43.53M

Day range


$8.61 - $9.00

52 week range


$7.11 - $10.04

Insider Ownership Transactions

Total Amount Purchased: -26,183.00 | $ -232,766.87

Date Type Amount Purchased Purchaser
2023-11-24 Sale -84.00 Feldschuh Michael Richard
2023-11-13 Buy 401.00 Feldschuh Michael Richard
2023-11-02 Sale -2000.00 Michel Robert J
2023-10-16 Buy 500.00 Michel Robert J
2023-09-20 Sale -25000.00 Estate of Joseph Feldschuh

SEC Fillings


Form Type Description Pages Date
n-csr/a Other 3 Mar 19, 2024
n-cen Other 2 Mar 15, 2024
n-csr Other 5 Mar 15, 2024
nt-ncsr/a Quarterly Reports 1 Mar 08, 2024
4 Insider transactions 1 Mar 06, 2024
nt-ncsr/a Quarterly Reports 1 Feb 29, 2024
nt-ncsr Quarterly Reports 1 Feb 29, 2024
8-k 8K-related 14 Jan 02, 2024
4 Insider transactions 1 Dec 06, 2023
4 Insider transactions 1 Dec 01, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.